US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle

      Summary Company Announcement Date: March 23, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Drug Recalls / Proton Pump Inhibitors (PPIs) / The Purple Pill in the Red Zone

The Purple Pill in the Red Zone

October 18, 2017 By US Recall News Leave a Comment

Purple Pill

Unaware of the potential life-threatening side-effects allegedly linked to the proton-pump-inhibitor (PPI) group, coupled with the ease of availability over the counter, millions of people throughout the country have used this group of drugs to treat dyspepsia, peptic ulcer disease, and gastroesophageal reflux disease. PPIs differ in their drug interactions and the way they are broken down by the liver.

Nexium is the brand name for esomeprazole used to treat a number of stomach-related problems by blocking a proton pump and reducing the production of acid in the stomach. Due to its property of interfering with calcium absorption, Nexium has been linked to increased risk of osteoporosis and/or bone fractures, Chronic Kidney Disease (CKD), acute kidney injury, interstitial nephritis, and other kidney problems. What started as only a handful of lawsuits that had failed to qualify for MDL formation in February 2017, has now acquired the desired status owing to the increasing number of lawsuits. Other PPIs (Prilosec, Prevacid, Protonix, etc.) face similar allegations in litigation.

FDA Warnings

In 2010, the FDA released a safety communication based on results from studies conducted to test the link to bone fractures of the hip, wrist, or spine. The following year, the FDA ruled that the warning was only for the prescription-based long-term use of Nexium and required no label warnings for the OTC variety. In 2014, another safety warning was released for acute interstitial nephritis, a condition, if remained untreated, may become chronic leading to further complications that might require life-long dialysis treatment or a kidney transplant. However, no black-box warnings have been required yet.

Nexium: Important Lawsuits/Settlements/Fines

  • AstraZeneca is facing a lawsuit pending since 2014, in re: Nexium (Esomeprazole) Antitrust Litigation MDL No. 2409 as a non-settling defendant along with Ranbaxy in the U.S. District Court for the District of Massachusetts, for violating federal and state antitrust laws by excluding generic competition for Nexium. Filed against four defendants: AstraZeneca, Ranbaxy, Teva, and Dr. Reddy’s, the MDL was left with two non-settling defendants in October 2015, when Teva opted to pay $24 million and Dr. Reddy’s agreed to help the drug buyers at the trial against the other defendants.
  • In early 2015, AstraZeneca was asked to pay $20 million for promoting Nexium as a more effective choice for treating acid reflux as compared to Prilosec its nearly identical but less expensive sister drug. It also faced several lawsuits alleging that the company’s marketing campaigns tricked them into buying Nexium over Prilosec.
  • In 2015, the Justice Department announced that AstraZeneca had agreed to pay the U.S. government $7.9 million to resolve kickback allegations involving Nexium.
  • Mid 2015, the Justice Department also announced that AstraZeneca agreed to pay the U.S. and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program.

Nexium Bone Injury Lawsuit

The FDA warnings, research studies, and growing awareness resulted in the filing of several Nexium lawsuits. A multi-district litigation (MDL): 2404 in the U.S. District Court for the Central District of California presided over by Judge Dale S. Fisher was established in December 2012, for bone injury cases. However, this was closed in October 2014, with the judgment passed in favor of manufacturer defendant.

Nexium Kidney Damage Lawsuit

In August 2017, realizing the growing size of Nexium mass tort claims, centralization of all the Nexium, Prilosec, and Prevacid alleged kidney injury cases resulted in the formation of MDL 2789 presided by Hon. Claire C. Cecchi, U.S.D.J. and Hon. Mark Falk, U.S.M.J. Plaintiffs allege that the drug-makers knew or should have known about the severe side-effects of the drugs in question and that they withheld information from the medical community and consumers. More than 275 lawsuits have been centralized; the count is expected to grow eventually. The District of New Jersey was selected as the venue of choice as lawsuits were already pending there, and it was convenient for most plaintiffs including the defendant manufacturers. The MDL is now in discovery stage that began with a case management meeting this October to discuss details required to advance the litigation necessary for pretrial discovery. The litigation will soon witness selection of Bellwether cases.

This article was submitted by Neural IT. Neural IT provides cost-effective and timely medical reviews for screening potential mass tort cases. For more information, please visit www.neuralit.com. You may email them at [email protected] or call +1-844-NIT-TEAM (648-8326).

Disclaimer: The content provided on this website is provided for general informational. It is not intended as, nor should it be considered as a reference for any medical or legal advice. The information provided should be used at your own risk based on your judgment. You assume full responsibility and liability for your own actions.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Drug Recalls, Proton Pump Inhibitors (PPIs)

About US Recall News

US Recall News provides recall news and information to the United States general public. Find all of the latest drug, food, products, and vehicle recall news as reported by U.S. government agencies and more.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle

March 23, 2023 By The FDA

Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards

March 22, 2023 By The CPSC

Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)

March 22, 2023 By The CPSC

Free Proton pump inhibitors Case Evalutaion

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces

March 20, 2023 By The FDA

Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders Blend, 8 Lb Bag, Due to Elevated Levels of Aflatoxin

March 18, 2023 By The FDA

Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula

March 16, 2023 By The FDA

Mockingbird Expands Recall to Include Single Strollers Due to Fall Hazard

March 16, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula

March 16, 2023 By The FDA

Mockingbird Expands Recall to Include Single Strollers Due to Fall Hazard

March 16, 2023 By The CPSC

Updated – Scenic Fruit Company Recalls Frozen Organic Strawberries and Frozen Organic Tropical Blend Because of Possible Health Risk

March 15, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle
  • Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards
  • Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)
  • Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
    Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
    (Recall Alert)
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
  • Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”
  • Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces
  • Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders Blend, 8 Lb Bag, Due to Elevated Levels of Aflatoxin
  • Perrigo Announces Voluntary Recall of Limited Quantity of Gerber® Good Start® SootheProTM Powdered Infant Formula
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in